Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is R  [Clear All Filters]
2024
Webbers SDs, Aarts CEm, Klein B, Koops D, Geissler J, Tool ATj, van Bruggen R, van den Akker E, Kuijpers TW. Reduced myeloid commitment and increased uptake by macrophages of stem cell-derived HPS2 neutrophils. Life Sci Alliance. 2024;7(4).
Park S, Bang S-Y, Kwag D, Lee JHyuk, Kim TYoon, Lee J, Min GJune, Park SSoo, Yahng S-A, Jeon Y-W, et al. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone Marrow Transplant. 2024.
Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS. Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol. 2024;15:1369243.
Soomann M, Prader S, Monteiro APinto, Zeilhofer U, Hauri-Hohl M, Güngör T, Schmid JPachlopnik, Trück J, Felber M. Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening. J Clin Immunol. 2024;44(1):39.
Wildey A, Harrington S, Stehno-Bittel L, Karanu F. Reduction of Activin A gives rise to comparable expression of key definitive endoderm and mature beta cell markers. Regen Med. 2024.
Wijaya CSugiarto, Xu S. Reevaluating Golgi fragmentation and its implications in wound repair. Cell Regen. 2024;13(1):4.
Nookaew I, Xiong J, Onal M, Bustamante-Gomez C, Wanchai V, Fu Q, Kim H-N, Almeida M, O'Brien CA. Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone. J Biol Chem. 2024:107158.
Zhang R, Zhao X, Li W, Gao Y. Refractory Anti-N-Methyl-d-Aspartate Receptor Autoimmune Encephalitis Induced by Ovarian Teratoma: A Case Report. Clin Neuropharmacol. 2024.
Malfona F, Testi AMaria, Chiaretti S, Moleti MLuisa. Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies. Blood Lymphat Cancer. 2024;14:1-15.
Pando-Caciano A, Escudero-Ramirez KAdid, Torres-Rodríguez JCarol, Maita-Malpartida H. Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report. Front Med (Lausanne). 2024;11:1335969.
Parain K, Chesneau A, Locker M, Borday C, Perron M. Regeneration from three cellular sources and ectopic mini-retina formation upon neurotoxic retinal degeneration in Xenopus. Glia. 2024.
Lath YV, Thool AR, Jadhav I. Regeneration of the Retina Using Pluripotent Stem Cells: A Comprehensive Review. Cureus. 2024;16(2):e53479.
Seker S, Lalegül-Ülker Ö, Elcin AEser, Elçin YMurat. Regeneration of Volumetric Muscle Loss Using MSCs Encapsulated in PRP-Derived Fibrin Microbeads. Methods Mol Biol. 2024.
Shrestha S, Acharya P, Kang S-Y, Vanga MGoud, Lekkala VKumar Redd, Liu J, Yang Y, Joshi P, Lee M-Y. Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays. bioRxiv. 2024.
Leng W, Li X, Dong L, Guo Z, Ji X, Cai T, Xu C, Zhu Z, Lin J. The Regenerative Microenvironment of the Tissue Engineering for Urethral Strictures. Stem Cell Rev Rep. 2024.
Wang X, Hu L, Wei B, Wang J, Hou D, Deng X. Regenerative therapies for femoral head necrosis in the past two decades: a systematic review and network meta-analysis. Stem Cell Res Ther. 2024;15(1):21.
Niu Y, Ji J, Yao K, Fu Q. Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges. Adv Ophthalmol Pract Res. 2024;4(2):52-64.
Nln I, Shum J, Ghodke-Puranik Y, Tipon R, Triese D, Amin S, Makol A, Osborn T, Chowdhary V, Thanarajasingam U, et al. Regional european genetic ancestry predicts type I interferon level and risk of severe viral infection. QJM. 2024.
Morimoto K, Suzuki H, Kuno A, Daitoku Y, Tanimoto Y, Kato K, Murata K, Sugiyama F, Mizuno S. Regional random mutagenesis driven by multiple sgRNAs and diverse on-target genome editing events to identify functionally important elements in non-coding regions. Open Biol. 2024;14(4):240007.
Wang S, Wang X, Shan Y, Tan Z, Su Y, Cao Y, Wang S, Dong J, Gu J, Wang Y. Region-specific cellular and molecular basis of liver regeneration after acute pericentral injury. Cell Stem Cell. 2024.
Mongiardi MPatrizia, Pallini R, D'Alessandris QGiorgio, Levi A, Falchetti MLaura. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness. Expert Rev Mol Med. 2024;26:e5.
Wu F, Chen S, Ren S, Wang R, Tan Y, Chen R, Li B, Cao H, Li J. Regulating Lipid Metabolism via Mitochondrial Dynamics in Tongue Squamous Cell Carcinoma Cancer Stem Cells. Recent Pat Anticancer Drug Discov. 2024.
Shah K, He S, Turner DJ, Corbo J, Rebbani K, Dominguez D, Bateman JM, Cheloufi S, Igreja C, Valkov E, et al. Regulation by the RNA-binding protein Unkempt at its effector interface. Nat Commun. 2024;15(1):3159.
Kosianova А, Pak O, Bryukhovetskiy I. Regulation of cancer stem cells and immunotherapy of glioblastoma (Review). Biomed Rep. 2024;20(2):24.
Lee YJin, Shin KJin, Chae YChan. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024.

Pages